N. E. Rosenstein, B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes, , 2001.

O. B. Harrison, J. E. Bray, M. C. Maiden, and D. A. Caugant, Genomic Analysis of 340 the Evolution and Global Spread of Hyper-invasive Meningococcal Lineage 5, 2015.

, EBioMedicine, vol.2, pp.234-243

C. T. Sacchi, A. P. De-lemos, M. C. Camargo, A. M. Whitney, C. E. Melles et al., , p.343

C. E. Frasch and L. W. Mayer, Meningococcal disease caused by Neisseria 344 meningitidis serogroup B serotype 4 in Sao Paulo, Brazil, Rev, vol.345, 1990.

, Inst Med Trop Sao Paulo, vol.40, pp.65-70

U. Vogel, M. K. Taha, J. A. Vazquez, J. Findlow, H. Claus et al., Caugant, vol.347

. Da, P. Kriz, R. Abad, S. Bambini, A. Carannante et al., , p.348

M. Frosch, G. Frosi, S. Gilchrist, M. M. Giuliani, E. Hong et al., , p.350

D. Thompson, M. Pizza, R. Rappuoli, D. Serruto, and M. Comanducci, , p.351

G. Donnelly, J. J. Medini, D. Borrow, and R. , Predicted strain coverage of a 352 meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative 353 and quantitative assessment, Lancet Infect Dis, vol.13, pp.416-441, 2013.